Opiant Pharmaceuticals Inc (NASDAQ:OPNT)
| 32.53 Delayed Data As of Dec 03 |  +2.93 / +9.90%Today’s Change | 7.86 Today|||52-Week Range 32.77 | +305.11% Year-to-Date |
Latest OPNT News | Press Releases
No recent news for Opiant Pharmaceuticals Inc.
Today’s Trading
| Previous close | 29.60 |
| Today’s open | 31.00 |
| Day’s range | 28.91 - 32.53 |
| Volume | 2,910 |
| Average volume (3 months) | 55,384 |
| Market cap | $136.5M |
Data as of 4:00pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | -115.18% |
| Earnings growth (this year) | +197.73% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -26.89% |
| P/E ratio | 130.1 |
| Price/Sales | 1.15 |
| Price/Book | 3.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTICCTI Biopharma Corp | +0.17 | +11.46% |
| MNOVMediciNova Inc | -0.04 | -1.27% |
| VIRXViracta Therapeutics... | -0.18 | -4.21% |
| ESPREsperion Therapeutic... | -3.73 | -41.58% |
Data as of 4:53pm ET, 12/03/2021
Financials
| Next reporting date | March 24, 2022 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $29.6M |
| Annual profit (last year) | -$1.9M |
| Net profit margin | -6.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Santa Monica, California |
Forecasts
